Chilton Capital Management LLC Procept Bio Robotics Corp Transaction History
Chilton Capital Management LLC
- $2.19 Billion
- Q2 2024
A detailed history of Chilton Capital Management LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Chilton Capital Management LLC holds 125 shares of PRCT stock, worth $9,941. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$9,941
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRCT
# of Institutions
214Shares Held
36.3MCall Options Held
251KPut Options Held
101K-
Vanguard Group Inc Valley Forge, PA4.71MShares$375 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$277 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.81MShares$144 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.75MShares$139 Million0.07% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.37MShares$109 Million0.53% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.55B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...